Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
The COVID-19 pandemic has laid bare the incapacity of capitalism to deal with the problems of mass society, and that this ...
We’ve learned a lot about COVID-19 over the last five years, but big questions remain. Recent federal actions may hinder the disease’s management.
SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.
FRONTLINE and our partners have been covering the pandemic and its fallout in the U.S. and around the world since COVID-19 broke out. Revisit our reporting.
A large-scale French study finds that patients hospitalized with COVID-19 face a significantly higher risk of long-term organ ...
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.